Skip to content

Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities

Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Municipalities

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07463001
Enrollment
240
Registered
2026-03-10
Start date
2026-03-23
Completion date
2029-03-01
Last updated
2026-03-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

School Attendance Problems

Keywords

School attendance problems, Back2School, Norway, Randomized controlled trial, Cognitive Behavioral Therapy, Children and adolescents

Brief summary

In this study we will investigate the effects of an intervention called Back2School, revised and adapted for Norwegian conditions on school attendance. A total of 240 participants will be recruited. All participants who have been enrolled will receive the intervention. Half of the participants will receive the intervention without delay (the experiment group), and the other half will receive it following a 13-week period (the control group). Following consent, screening for eligibility and randomization, the intervention will start with an assessment related to the individual participant and condition at the participants' school. Based on this a shared understanding and an intervention plan is developed. Over a 13-week period the youth, the family and the school, work together guided by the municipal team to increase attendance and solve problems related to this. Assessments will be carried out after the intervention and 6 months later.

Interventions

BEHAVIORALBack2School

The revised Back2S school manual consists of an initial assessment, a case formulation conference, 16 sessions and 3 meetings with different participants (parents, youth, school personnel) over 13 weeks. There is a booster session 12 weeks after the final session and one 24 weeks after the final session.

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER
The Research Council of Norway
CollaboratorOTHER
University of Tromso
CollaboratorOTHER
University of Bergen
CollaboratorOTHER
Regionsenter for barn og unges psykiske helse
CollaboratorOTHER
Regionalt kunnskapssenter for barn og unge - Nord
CollaboratorUNKNOWN
NORCE Norwegian Research Centre AS
CollaboratorOTHER
University of Stavanger
CollaboratorOTHER
University of Aarhus
CollaboratorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
NONE

Intervention model description

A Randomized Controlled Trial, 2-arm study, to investigate the effectiveness of the optimized Back2School intervention compared with Wait List Control (WLC) in improving school attendance in youth aged 9-15 with school attendance problems

Eligibility

Sex/Gender
ALL
Age
9 Years to 15 Years
Healthy volunteers
No

Inclusion criteria

1. Participants must be between the ages of 9 and 15 at the time of enrollment. 2. Participants must have less than 80% attendance for the last 12 weeks of school at the time of screening. 3. At least one parent has to talk and understand Norwegian. 4. At least one parent has to be motivated to participate. 5. The school must agree to participate in the intervention

Exclusion criteria

1 The participant has a known diagnosis of autism-spectrum disorder, psychosis, and/or eating disorder. 2\. Participant needs acute psychiatric intervention.

Design outcomes

Primary

MeasureTime frameDescription
School attendanceDirect: Avg at Baseline, 2 weeks at end (13 weeks from baseline), 2 weeks at 6 months (37 w from baseline) Delayed: Avg at baseline, 2 weeks before start (13 w from baseline) 2 weeks at end (28 w from baseline), 2 weeks at 6 months (54 w from baseline)School attendance measured on a daily basis by teacher.
General functioningDirect start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)Impact on daily life as measured by the SDQ impact scale

Secondary

MeasureTime frameDescription
Change in Quality of lifeDirect start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)Measures perceived quality of life as reported by parents and child using Kidscreen 10
Change in symptoms of anxietyDirect start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)Measures change in symptoms of anxiety as measured by the SCAS reported by parents and child
Change in symptoms of DepressionDirect start group: Will be measured at Baseline (T1), Week 15 from baseline (T2), Week 37 from baseline (T3) Delayed access group: Baseline (T1), Week 15 from Baseline (T1a), Week 29 from baseline (T2), Week 54 from baseline (T3)Change in symptoms of depression reported by child and parents using the SMFQ

Countries

Norway

Contacts

CONTACTJo M Ingul, phd
jo.m.ingul@ntnu.no+4792869163
CONTACTKristin Ytreland, phd
kristin.ytreland@ntnu.no
PRINCIPAL_INVESTIGATORJo Magne Ingul, phd

Norwegian University of Science and Technology

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 11, 2026